FORTUNE Small Business Again Lists Meridian Bioscience as One of America`s Fastest-Growing Small Companies

CINCINNATI--(Business Wire)--
Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) announced today that
FORTUNE Small Business has ranked Meridian Bioscience, Inc. number 34 on their
ninth annual FSB 100 list of the fastest growing small public companies in
America. The list appears in the July/August issue of FORTUNE Small Business and
is available online at http://money.cnn.com/magazines/fsb/fsb100/2009/.

To compile the ninth annual list, FORTUNE Small Business asked financial
research firm Zacks to rank public companies with revenues less than $200
million and a stock price of more than $1 by their three-year annualized rate of
revenue growth and return to investors.

John A. Kraeutler, Chief Executive Officer, stated, "For the fifth year in a row
Meridian Bioscience has been ranked among the top 100 fastest growing companies
by FORTUNE Small Business magazine. This acknowledgement is sincerely
appreciated. Our performance in delivering shareholder value, while helping
improve the diagnosis of disease, is directly due to our outstanding employees
and our valuable customers around the globe."

Meridian is a fully integrated life science company that manufactures, markets
and distributes a broad range of innovative diagnostic test kits, purified
reagents and related products and offers biopharmaceutical enabling
technologies. Utilizing a variety of methods, these products and diagnostic
tests provide accuracy, simplicity and speed in the early diagnosis and
treatment of common medical conditions, such as gastrointestinal, viral and
respiratory infections. Meridian`s diagnostic products are used outside of the
human body and require little or no special equipment. The Company's products
are designed to enhance patient well-being while reducing the total outcome
costs of healthcare. Meridian has strong market positions in the areas of
gastrointestinal and upper respiratory infections, serology, parasitology and
fungal disease diagnosis. In addition, Meridian is a supplier of rare reagents,
specialty biologicals and related technologies used by biopharmaceutical
companies engaged in research for new drugs and vaccines. The Company markets
its products and technologies to hospitals, reference laboratories, research
centers, veterinary testing centers, physician offices, diagnostics
manufacturers and biotech companies in more than 60 countries around the world.
The Company`s shares are traded through NASDAQ`s Global Select Market, symbol
VIVO. Meridian's website address is www.meridianbioscience.com.

Meridian Bioscience, Inc.
John A. Kraeutler, CEO, 513-271-3700

Copyright Business Wire 2009